TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
6 hedge funds and large institutions have $600K invested in TIANYIN PHARMACEUTICAL in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
34% less capital invested
Capital invested by funds: $908K → $600K (-$308K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$3.54K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.97K |
Top Sellers
| 1 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$373 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $335K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $174K | +$3.54K | +11,700 | +2% |
|
3
California Public Employees Retirement System
Sacramento,
California
| $73K | – | – | – |
|
|
CHP
4
Cable Hill Partners
Portland,
Oregon
| $12K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $5K | +$2.97K | +9,791 | +83% |
|
|
6
UBS Group
Zurich,
Switzerland
| $1K | -$373 | -1,233 | -25% |
|
|
RIM
7
Regent Investment Management
Louisville,
Kentucky
| – | -$8K | -16,600 | Closed |
|
TPI Hedge Fund Activity: Q3 2015 in Review
6 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q3 2015, worth a combined $600K — down 34% from $908K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TPI and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.54K. The largest seller was Regent Investment Management, exiting entirely with an estimated $8K sold.
- 6 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q3 2015, down from 7 in Q2 2015.
- Funds reported $600K of TIANYIN PHARMACEUTICAL stock for Q3 2015, down 34% quarter-over-quarter.
- 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest TIANYIN PHARMACEUTICAL buyer in Q3 2015 was Renaissance Technologies, an estimated $3.54K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q3 2015 was Regent Investment Management, an estimated $8K sold.
Based on aggregated 13F filings for Q3 2015.